A Study of Fixed Dose Versus Serum Level-Based Titration Regimen of Vitamin D Supplementation in Dialysis Patients
NCT05434377 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78
Last updated 2024-02-08
Summary
Vitamin D insufficiency, defined as serum 25-hydroxyvitamin (OH) D level less than 30 ng/ml, is highly prevalent not only in the general population but also in chronic kidney disease (CKD) population. Many guidelines including the National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) have consistently recommended vitamin D supplementation in patients with pre-dialysis CKD with vitamin D insufficiency with ergocalciferol or cholecalciferol to achieve 25(OH)D level of more than 30 ng/ml using serum levels-based titration regimen. However, this protocol has not been studied in end stage kidney disease patients treated with maintenance dialysis.
Conditions
- Vitamin D Deficiency
- End Stage Renal Disease
Interventions
- OTHER
-
ergocalciferol supplementation
Participants in both groups will recieve ergocalciferol with different supplementation regimens for 6 months.
- OTHER
-
dialysis techniques
Both groups will have participants treated with maintenance hemodialysis and peritoneal dialysis.
- OTHER
-
sunlight exposure time
Both groups will be advised to receive similar hours of daily sunlight exposure time.
Sponsors & Collaborators
-
Chulalongkorn University
lead OTHER
Principal Investigators
-
Piyawan Kittiskulnam · Chulalongkorn University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-01
- Primary Completion
- 2023-05-31
- Completion
- 2023-12-31
Countries
- Thailand
Study Locations
More Related Trials
-
Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients
NCT00958451 ·Status: COMPLETED ·Phase: PHASE4
-
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
NCT01312441 ·Status: TERMINATED ·Phase: PHASE4
-
Ergocalciferol in Chronic Kidney Disease
NCT00411294 ·Status: COMPLETED
-
Hemodialysis Vitamin D Pilot
NCT01214928 ·Status: COMPLETED ·Phase: NA
-
Cholecalciferol on Hemodialysis Patients
NCT03602430 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Impact of Vitamin D Therapies on Chronic Kidney Disease
NCT01222234 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Comparison of Vitamin's D2 and D3 in Stage 5 Chronic Kidney Disease Patients on Chronic Hemodialysis
NCT01675557 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Vitamin D Supplementation on Balance in CKD
NCT03710161 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2
NCT01561222 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Vitamin D on Endothelial Function and Blood Biomarkers Including CD28 Null Cells in CKD
NCT02005718 ·Status: COMPLETED ·Phase: PHASE3
-
Vitamin D and Cardiac Autonomic Tone in Hemodialysis
NCT01774812 ·Status: COMPLETED ·Phase: PHASE2
-
How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
NCT00528788 ·Status: COMPLETED ·Phase: PHASE4
-
Ergocalciferol Therapy in Calcidiol Deficient, Hemodialysis Patients on Therapeutic Doses of Paricalcitol
NCT02011828 ·Status: COMPLETED ·Phase: PHASE1
-
Vitamin D and Carboxy PTH Fragments in Coronary Calcification
NCT00502268 ·Status: WITHDRAWN ·Phase: PHASE4
-
Vitamin D, Chronic Kidney Disease (CKD) and the Microcirculation
NCT00882401 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease
NCT00677534 ·Status: COMPLETED ·Phase: NA
-
Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients
NCT02999204 ·Status: COMPLETED ·Phase: PHASE4
-
Vitamin D Replacement After Kidney Transplant
NCT00748618 ·Status: COMPLETED ·Phase: NA
-
Immune Effects of Vitamin D in Hemodialysis Patients
NCT00686751 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease
NCT01364688 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Oral Ergocalciferol to Treat Pruritis in Hemodialysis Patients
NCT01114672 ·Status: COMPLETED ·Phase: PHASE4
-
Underlying Causes of Low Vitamin K Status in Hemodialysis Patients
NCT03493087 ·Status: COMPLETED ·Phase: NA
-
Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease
NCT01426724 ·Status: WITHDRAWN ·Phase: NA
-
Vitamin D 2 to Dialysis Patients
NCT00535158 ·Status: TERMINATED
-
Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis
NCT02598635 ·Status: UNKNOWN ·Phase: PHASE4